![Stacy Taylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacy Taylor is the founder of EndiCOR Medical, Inc. founded in 1990.
Former job at DLA Piper LLP (United States) as Co-Chairman-Medical Device Practice.
Former job at BTG International, Inc. as Senior Assistant General Counsel.
Former job at Adaptive Biotechnologies Corp.
as Secretary, Senior Vice President & General Counsel.
Education from California Polytechnic State University (San Luis Obispo) with an undergraduate degree.
| Unternehmen | Position | Ende |
|---|---|---|
EndiCOR Medical, Inc. | Gründer | - |
DLA Piper LLP (United States)
 DLA Piper LLP (United States) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Corporate Officer/Principal | - |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
EndiCOR Medical, Inc. | |
DLA Piper LLP (United States)
DLA Piper LLP (United States) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
